Cibc Bancorp Usa Inc. Ligand Pharmaceuticals Inc Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 2,183 shares of LGND stock, worth $455,592. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,183Holding current value
$455,592% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
312Shares Held
19.9MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$599 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$433 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$221 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3752KShares$157 Million0.16% of portfolio
-
State Street Corp Boston, MA750KShares$156 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.52B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...